Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 4/2012

01-04-2012 | Article

Prevalence and risk factors for quinolone resistance among Escherichia coli strains isolated from males with community febrile urinary tract infection

Authors: A. Smithson, C. Chico, J. Ramos, C. Netto, M. Sanchez, J. Ruiz, R. Porron, M. T. Bastida

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 4/2012

Login to get access

Abstract

The purpose of this study was to evaluate the prevalence and clinical risk factors for quinolone resistance (QR) in E. coli strains from males with febrile urinary tract infection (FUTI). An ambispective cross-sectional study was performed in which we evaluated 153 males with a community FUTI caused by E. coli. Among the 153 FUTI episodes, 101 (66%) were due to quinolone susceptible E. coli strains while 52 (34%) were caused by QR E. coli strains. In the univariate analysis QR was associated with older age, higher Charlson scores, dementia, past UTI, urinary tract abnormalities, previous antibiotic use, particularly with fluoroquinolones (FQ), a healthcare-associated (HA)-UTI (HA-UTI) and to four of the components included in the definition of HA-UTI: hospital admission, nursing home residence, indwelling urethral catheter and invasive urinary instrumentation. In the multivariate analysis, HA-UTI (OR 3.82, 95% CI 1.3–11.24; P 0.015) and use of antimicrobials in the previous month (OR 5.82, 95% CI 2.3–14.88; P < 0.001) mainly with FQ (OR 13.97, 95% CI 2.73–71.53; P 0.002) were associated with QR. To have a HA-UTI and a previous use of FQ in the preceding month were strong risk factors for QR E. coli, and thus empirical antimicrobial treatment with quinolones should be avoided in these patients.
Literature
1.
go back to reference Ulleryd P (2003) Febrile urinary tract infection in men. Int J Antimicrob Agents 22(Suppl 2):89–93PubMedCrossRef Ulleryd P (2003) Febrile urinary tract infection in men. Int J Antimicrob Agents 22(Suppl 2):89–93PubMedCrossRef
2.
go back to reference Horcajada JP, Vilana R, Moreno-Martínez A, Alvarez-Vijande R, Bru C, Bargallo X, Buñesch L, Martinez JA, Mensa J (2003) Transrectal prostatic ultrasonography in acute bacterial prostatitis: findings and clinical implications. Scand J Infect Dis 35:114–120PubMedCrossRef Horcajada JP, Vilana R, Moreno-Martínez A, Alvarez-Vijande R, Bru C, Bargallo X, Buñesch L, Martinez JA, Mensa J (2003) Transrectal prostatic ultrasonography in acute bacterial prostatitis: findings and clinical implications. Scand J Infect Dis 35:114–120PubMedCrossRef
3.
go back to reference Velasco M, Mateos JJ, Martínez JA, Moreno-Martinez A, Horcajada JP, Barranco M, Lomeña F, Mensa J (2004) Accurate topographical diagnosis of urinary tract infection in male patients with (111) indium-labelled leukocyte scintigraphy. Eur J Intern Med 15:157–161PubMedCrossRef Velasco M, Mateos JJ, Martínez JA, Moreno-Martinez A, Horcajada JP, Barranco M, Lomeña F, Mensa J (2004) Accurate topographical diagnosis of urinary tract infection in male patients with (111) indium-labelled leukocyte scintigraphy. Eur J Intern Med 15:157–161PubMedCrossRef
4.
go back to reference Krieger JN, Nyberg L, Nickel JC (1999) NIH consensus definition and classification of prostatitis. JAMA 282:236–237PubMedCrossRef Krieger JN, Nyberg L, Nickel JC (1999) NIH consensus definition and classification of prostatitis. JAMA 282:236–237PubMedCrossRef
5.
go back to reference Naber KG, Sörgel F (2003) Antibiotic therapy: rationale and evidence for optimal drug concentrations in prostatic and seminal fluid and prostatic tissue. Andrologia 35:331–335PubMed Naber KG, Sörgel F (2003) Antibiotic therapy: rationale and evidence for optimal drug concentrations in prostatic and seminal fluid and prostatic tissue. Andrologia 35:331–335PubMed
6.
go back to reference Johnson L, Sabel A, Burman WJ, Everhart RM, Rome M, MacKenzie TD, Rozwadowski J, Mehler PS, Price CS (2008) Emergence of fluoroquinolone resistance in outpatient urinary Escherichia coli isolates. Am J Med 121:876–884PubMedCrossRef Johnson L, Sabel A, Burman WJ, Everhart RM, Rome M, MacKenzie TD, Rozwadowski J, Mehler PS, Price CS (2008) Emergence of fluoroquinolone resistance in outpatient urinary Escherichia coli isolates. Am J Med 121:876–884PubMedCrossRef
8.
go back to reference Killgore KM, March KL, Guglielmo BJ (2004) Risk factors for community-acquired ciprofloxacin-resistant Escherichia coli urinary tract infection. Ann Pharmacother 38:1148–1152PubMedCrossRef Killgore KM, March KL, Guglielmo BJ (2004) Risk factors for community-acquired ciprofloxacin-resistant Escherichia coli urinary tract infection. Ann Pharmacother 38:1148–1152PubMedCrossRef
9.
go back to reference Arslan H, Azap OK, Ergönül O, Timurkaynak F, Urinary Tract Infection Study Group (2005) Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey. J Antimicrob Chemother 56:914–918PubMedCrossRef Arslan H, Azap OK, Ergönül O, Timurkaynak F, Urinary Tract Infection Study Group (2005) Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey. J Antimicrob Chemother 56:914–918PubMedCrossRef
10.
go back to reference Colodner R, Kometiani I, Chazan B, Raz R (2008) Risk factors for community-acquired urinary tract infection due to quinolone-resistant E. coli. Infection 36:41–45PubMedCrossRef Colodner R, Kometiani I, Chazan B, Raz R (2008) Risk factors for community-acquired urinary tract infection due to quinolone-resistant E. coli. Infection 36:41–45PubMedCrossRef
11.
go back to reference Lautenbach E, Fishman NO, Bilker WB, Castiglioni A, Metlay JP, Edelstein PH, Strom BL (2002) Risk factors for fluoroquinolone resistance in nosocomial Escherichia coli and Klebsiella pneumoniae infections. Arch Intern Med 162:2469–2477PubMedCrossRef Lautenbach E, Fishman NO, Bilker WB, Castiglioni A, Metlay JP, Edelstein PH, Strom BL (2002) Risk factors for fluoroquinolone resistance in nosocomial Escherichia coli and Klebsiella pneumoniae infections. Arch Intern Med 162:2469–2477PubMedCrossRef
12.
go back to reference Etienne M, Chavanet P, Sibert L, Michel F, Levesque H, Lorcerie B, Doucet J, Pfitzenmeyer P, Caron F (2008) Acute bacterial prostatitis: heterogeneity in diagnostic criteria and management. Retrospective multicentric analysis of 371 patients diagnosed with acute prostatitis. BMC Infect Dis 30:8–12 Etienne M, Chavanet P, Sibert L, Michel F, Levesque H, Lorcerie B, Doucet J, Pfitzenmeyer P, Caron F (2008) Acute bacterial prostatitis: heterogeneity in diagnostic criteria and management. Retrospective multicentric analysis of 371 patients diagnosed with acute prostatitis. BMC Infect Dis 30:8–12
14.
go back to reference Friedman ND, Kaye KS, Stout JE, McGarry SA, Trivette SL, Briggs JP, Lamm W, Clark C, MacFarquhar J, Walton AL, Reller LB, Sexton DJ (2002) Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 137:791–797PubMed Friedman ND, Kaye KS, Stout JE, McGarry SA, Trivette SL, Briggs JP, Lamm W, Clark C, MacFarquhar J, Walton AL, Reller LB, Sexton DJ (2002) Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 137:791–797PubMed
15.
go back to reference Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method for classifying comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383PubMedCrossRef Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method for classifying comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383PubMedCrossRef
16.
go back to reference Lipsky BA, Ireton RC, Fihn SD, Hackett R, Berger RE (1987) Diagnosis of bacteriuria in men: specimen collection and culture interpretation. J Infect Dis 155:847–854PubMedCrossRef Lipsky BA, Ireton RC, Fihn SD, Hackett R, Berger RE (1987) Diagnosis of bacteriuria in men: specimen collection and culture interpretation. J Infect Dis 155:847–854PubMedCrossRef
17.
go back to reference CLSI (2007) Performance Standards for antimicrobial susceptibility testing: 17th informational supplement. CLSI document M100S17. Clinical and Laboratory Standard Institute, Wayne, PA CLSI (2007) Performance Standards for antimicrobial susceptibility testing: 17th informational supplement. CLSI document M100S17. Clinical and Laboratory Standard Institute, Wayne, PA
18.
go back to reference Rodríguez-Baño J, Alcalá JC, Cisneros JM, Grill F, Oliver A, Horcajada JP, Tórtola T, Mirelis B, Navarro G, Cuenca M, Esteve M, Peña C, Llanos AC, Cantón R, Pascual A (2008) Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli. Arch Intern Med 168:1897–1902PubMedCrossRef Rodríguez-Baño J, Alcalá JC, Cisneros JM, Grill F, Oliver A, Horcajada JP, Tórtola T, Mirelis B, Navarro G, Cuenca M, Esteve M, Peña C, Llanos AC, Cantón R, Pascual A (2008) Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli. Arch Intern Med 168:1897–1902PubMedCrossRef
19.
go back to reference Velasco M, Horcajada JP, Mensa J, Mensa J, Moreno-Martinez A, Vila J, Martinez JA, Ruiz J, Barranco M, Roig G, Soriano E (2001) Decreased invasive capacity of quinolone-resistant Escherichia coli in patients with urinary tract infections. Clin Infect Dis 33:1682–1686PubMedCrossRef Velasco M, Horcajada JP, Mensa J, Mensa J, Moreno-Martinez A, Vila J, Martinez JA, Ruiz J, Barranco M, Roig G, Soriano E (2001) Decreased invasive capacity of quinolone-resistant Escherichia coli in patients with urinary tract infections. Clin Infect Dis 33:1682–1686PubMedCrossRef
20.
go back to reference Alos JI, Serrano MG, Gomez-Garces JL, Perianes J (2005) Antibiotic resistance of Escherichia coli from community-acquired urinary tract infections in relation to demographic and clinical data. Clin Microbiol Infect 11:199–203PubMedCrossRef Alos JI, Serrano MG, Gomez-Garces JL, Perianes J (2005) Antibiotic resistance of Escherichia coli from community-acquired urinary tract infections in relation to demographic and clinical data. Clin Microbiol Infect 11:199–203PubMedCrossRef
21.
go back to reference Koeijers JJ, Verbon A, Kessels AG, Bartelds A, Donkers G, Nys S, Stobberingh EE (2010) Urinary tract infection in male general practice patients: uropathogens and antibiotic susceptibility. Urology 76:336–340PubMedCrossRef Koeijers JJ, Verbon A, Kessels AG, Bartelds A, Donkers G, Nys S, Stobberingh EE (2010) Urinary tract infection in male general practice patients: uropathogens and antibiotic susceptibility. Urology 76:336–340PubMedCrossRef
22.
go back to reference Lautenbach E, Metlay JP, Mao X, Han X, Fishman NO, Bilker WB, Tolomeo P, Wheeler M, Nachamkin I (2010) The prevalence of fluoroquinolone resistance mechanisms in colonizing Escherichia coli isolates recovered from hospitalized patients. Clin Infect Dis 51:280–285PubMedCrossRef Lautenbach E, Metlay JP, Mao X, Han X, Fishman NO, Bilker WB, Tolomeo P, Wheeler M, Nachamkin I (2010) The prevalence of fluoroquinolone resistance mechanisms in colonizing Escherichia coli isolates recovered from hospitalized patients. Clin Infect Dis 51:280–285PubMedCrossRef
23.
go back to reference Hawkey PM (2003) Mechanisms of quinolone action and microbial response. J Antimicrob Chemother 51(Suppl 1):29–35PubMedCrossRef Hawkey PM (2003) Mechanisms of quinolone action and microbial response. J Antimicrob Chemother 51(Suppl 1):29–35PubMedCrossRef
24.
go back to reference Tavio MM, Vila J, Ruiz J, Martin-Sanchez AM, Jimenez de Anta MT (1999) Mechanisms involved in the development of resistance to fluoroquinolones in Escherichia coli. J Antimicrob Chemother 44:735–742PubMedCrossRef Tavio MM, Vila J, Ruiz J, Martin-Sanchez AM, Jimenez de Anta MT (1999) Mechanisms involved in the development of resistance to fluoroquinolones in Escherichia coli. J Antimicrob Chemother 44:735–742PubMedCrossRef
25.
go back to reference Poole K (2000) Efflux-mediated resistance to fluoroquinolones in gram-negative bacteria. Antimicrob Agents Chemother 44:2233–2241PubMedCrossRef Poole K (2000) Efflux-mediated resistance to fluoroquinolones in gram-negative bacteria. Antimicrob Agents Chemother 44:2233–2241PubMedCrossRef
26.
go back to reference Poirel L, Cattoir V, Nordmann P (2008) Is plasmid-mediated quinolone resistance a clinically significant problem? Clin Microbiol Infect 14:295–297PubMedCrossRef Poirel L, Cattoir V, Nordmann P (2008) Is plasmid-mediated quinolone resistance a clinically significant problem? Clin Microbiol Infect 14:295–297PubMedCrossRef
27.
go back to reference Costelloe C, Metcalfe C, Lovering A, Mant D, Hay AD (2010) Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis. BMJ 340:c2096. doi:10.1136/bmj.c2096 PubMedCrossRef Costelloe C, Metcalfe C, Lovering A, Mant D, Hay AD (2010) Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis. BMJ 340:c2096. doi:10.​1136/​bmj.​c2096 PubMedCrossRef
28.
go back to reference Horcajada JP, Vila J, Moreno-Martínez A, Ruiz J, Martínez JA, Sánchez M, Soriano E, Mensa J (2002) Molecular epidemiology and evolution of resistance to quinolones in Escherichia coli after prolonged administration of ciprofloxacin in patients with prostatitis. J Antimicrob Chemother 49:55–59PubMedCrossRef Horcajada JP, Vila J, Moreno-Martínez A, Ruiz J, Martínez JA, Sánchez M, Soriano E, Mensa J (2002) Molecular epidemiology and evolution of resistance to quinolones in Escherichia coli after prolonged administration of ciprofloxacin in patients with prostatitis. J Antimicrob Chemother 49:55–59PubMedCrossRef
29.
go back to reference Johnson JR, Scheutz F, Ulleryd P, Kuskowski MA, O’Bryan TT, Sandberg T (2005) Phylogenetic and pathotypic comparison of concurrent urine and rectal Escherichia coli isolates from men with febrile urinary tract infection. J Clin Microbiol 43:3895–3900PubMedCrossRef Johnson JR, Scheutz F, Ulleryd P, Kuskowski MA, O’Bryan TT, Sandberg T (2005) Phylogenetic and pathotypic comparison of concurrent urine and rectal Escherichia coli isolates from men with febrile urinary tract infection. J Clin Microbiol 43:3895–3900PubMedCrossRef
30.
go back to reference Mazzoli S (2010) Biofilms in chronic bacterial prostatitis (NIH-II) and in prostatic calcifications. FEMS Immunol Med Microbiol 59:337–344PubMed Mazzoli S (2010) Biofilms in chronic bacterial prostatitis (NIH-II) and in prostatic calcifications. FEMS Immunol Med Microbiol 59:337–344PubMed
31.
go back to reference Kadhiravan T, Wig N, Kapil A, Kabra SK, Renuka K, Misra A (2005) Clinical outcomes in typhoid fever: adverse impact of infection with nalidixic acid-resistant Salmonella typhi. BMC Infect Dis 5:37PubMedCrossRef Kadhiravan T, Wig N, Kapil A, Kabra SK, Renuka K, Misra A (2005) Clinical outcomes in typhoid fever: adverse impact of infection with nalidixic acid-resistant Salmonella typhi. BMC Infect Dis 5:37PubMedCrossRef
32.
go back to reference Ruiz J, Gomez J, Navia MM, Ribera A, Sierra JM, Marco F, Mensa J, Vila J (2002) High prevalence of nalidixic acid resistant, ciprofloxacin susceptible phenotype among clinical isolates of Escherichia coli and other Enterobacteriaceae. Diagn Microbiol Infect Dis 42:257–261PubMedCrossRef Ruiz J, Gomez J, Navia MM, Ribera A, Sierra JM, Marco F, Mensa J, Vila J (2002) High prevalence of nalidixic acid resistant, ciprofloxacin susceptible phenotype among clinical isolates of Escherichia coli and other Enterobacteriaceae. Diagn Microbiol Infect Dis 42:257–261PubMedCrossRef
Metadata
Title
Prevalence and risk factors for quinolone resistance among Escherichia coli strains isolated from males with community febrile urinary tract infection
Authors
A. Smithson
C. Chico
J. Ramos
C. Netto
M. Sanchez
J. Ruiz
R. Porron
M. T. Bastida
Publication date
01-04-2012
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 4/2012
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-011-1322-y

Other articles of this Issue 4/2012

European Journal of Clinical Microbiology & Infectious Diseases 4/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.